Pressmeddelanden
Coegin Pharma delivers first commercial batch of Follicopeptide products to Gents
Coegin Pharma AB ("Coegin" or the "Company") today announces that the Company has successfully produced and delivered its first commercial batch of hair growth products based on...
REG
Coegin Pharma's Nomination Committee appointed for the 2026 Annual General Meeting
The Nomination Committee of Coegin Pharma has been appointed in accordance with the guidelines for the Nomination Committee adopted at the Annual General Meeting on May 22, 2025....
REG
Coegin Pharma AB (publ) publishes its quarterly report for the third quarter of 2025
Summary of interim reportThe third quarter of 2025 marks a historic turning point for Coegin Pharma. The company has successfully transitioned from a development-focused biotech...
First Follicopeptide® powered product available for consumer pre-orders November 16 - a historic milestone for Coegin Pharma
Coegin Pharma AB ("Coegin" or "the Company") is proud to announce that starting November 16, customers can pre-order Gents Power Hair Activating Formula through Gents' online sto...
Coegin introduces new tailor-made Follicopeptide complementary product - launching early 2026
Coegin Pharma AB ("Coegin" or "the Company") announces that it has finalized the development of a new, tailor-made Follicopeptide complementary product. It is designed to strengt...
REG
MAR
Coegin Pharma enters collaboration with Hårklinikken - expands Follicopeptide® commercialization with a world renowned hair clinic brand
Coegin Pharma AB ("Coegin" or "the Company") has entered a collaboration with Hårklinikken, a global actor in premium, science-driven hair and scalp health, through the signing o...
Rapporter
Video
Finansiell kalender
Bokslutskommuniké 2025
Bokslutskommuniké
Om Coegin Pharma
Coegin Pharma är ett svenskt bioteknikföretag som utvecklar banbrytande innovationer för hår och hud.
Webbplats
www.coeginpharma.com
Bransch
Bioteknik
Prenumerera
Få löpande information från Coegin Pharma via e-post.
Handelsinformation
Kurs 4,8 SEK (2025-12-11)
Förändring 23,08% (2024-12-11)